Background
The SWAFAX project focussed on the development of new processing methods for the production bioactive rich extracts from European seaweeds and an investigation of their antioxidant and anti-inflammatory potential in vitro and in vivo. CyberColloids was responsible for developing the extracts which were evaluated at The Universities of Reading & Ulster, UK.
Outcome
A range of novel processes were developed which will enable the SME participants to either manufacture bioactive rich seaweed extract or to incorporate the extracts into existing product lines. 14 extracts were screened for antioxidant and anti-inflammatory potential and 1 extract was investigated in a series of studies using human volunteers. The project yielded a number of significant findings concerning the potential health benefits of the extracts e.g. bioavailability of seaweed polyphenols in humans. For an overview of the project click here.
For more detail on the research findings see –
- Baldrick et al (2018). Impact of a (poly)phenol-rich extract from the brown alga Ascophyllum nodosum on DNA damage and antioxidant activity in an overweight or obese population: a randomized controlled trial. American Journal of Clinical Nutrition,108:688–700.
- Corona et al (2016). Gastrointestinal modifications and bioavailability of brown seaweed phlorotannins and effects on inflammatory markers. British Journal of Nutrition, 115(7):1240-53.
- Corona et al (2017). Effect of simulated gastrointestinal digestion and fermentation on polyphenolic content and bioactivity of brown seaweed phlorotannin-rich extracts. Nutr. Food Res. 61, 11, 2017.
Other seaweed projects